|
|
|
Has come into the market for 10 years
Beijing Double-Crane Pharmaceutical Co., Ltd. (DCPC) was jointly established by six legal shareholders on May 15th 1997 and was successfully listed on May 22nd of the same year (Share Code: 600062).
Four development strategies
As a new & high-tech enterprise and the first approved GMP pharmaceutical company in China, DCPC has been advocating tenet of the company: Care for People and Promote Health. During the past ten years, DCPC has set up four great mainstays for business development including the largest i.v solution, injection supply base in China, China's leading production base for synthetic antibiotics, innovation base for natural drugs and nation-wide sale and service system. Through global collaboration department in above fields, DCPC has developed itself into a large modernized pharmaceutical enterprise with sales network around domestic and abroad, main business covering new drug development, pharmaceutical manufacturing, pharmaceutical operation and pharmaceutical equipment.
Broad business coverage and wide range of name brand products
By December 2006, it has annual sales about US$ 600 million, controlling shareholding in 17 subsidiaries and shares in 7 companies in most major cities throughout China. And its business covers areas of medical research, pro |
|
|
|
